All individuals in MeSH

Label Id Description
Drug Resistance, Viral D024882 [The ability of viruses to resist or to become tolerant to chemotherapeutic agents or antiviral agents. This resistance is acquired through gene mutation. ]
Drug Resistant Epilepsy D000069279 [Epileptic condition in which adequate trials of two tolerated and appropriately chosen and used ANTIEPILEPTIC DRUGS schedules to achieve sustained seizure freedom failed. ]
Drug Screening Assays, Antitumor D004354 [Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. ]
Drug Stability D004355 [The chemical and physical integrity of a pharmaceutical product. ]
Drug Storage D004356 [The process of keeping pharmaceutical products in an appropriate location. ]
Drug Substitution D057915 [The practice of replacing one prescribed drug with another that is expected to have the same clinical or psychological effect. ]
Drug Synergism D004357 [Agents used for augmenting the action of another drug. , The action of a drug in promoting or enhancing the effectiveness of another drug. ]
Drug Tapering D000084862 [Gradual discontinuation or reduction of a therapeutic dose of a particular drug over a period of time. ]
Drug Therapy D004358 [The use of DRUGS to treat a DISEASE or its symptoms. One example is the use of ANTINEOPLASTIC AGENTS to treat CANCER. ]
Drug Therapy, Combination D004359 [Therapy with two or more separate preparations given for a combined effect. ]
Drug Therapy, Computer-Assisted D004360 [Adjunctive computer programs in providing drug treatment to patients. ]
Drug Tolerance D004361 [Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. ]
Drug Trafficking D064423 [The illegal acquisition, sale, production, transport, movement, and distribution of controlled substances such as narcotics. ]
Drug Users D055030 [People who take drugs for a non-therapeutic or non-medical effect. The drugs may be legal or illegal, but their use often results in adverse medical, legal, or social consequences for the users. ]
Drug Utilization D004363 [The utilization of drugs as reported in individual hospital studies, FDA studies, marketing, or consumption, etc. This includes drug stockpiling, and patient drug profiles. ]
Drug Utilization Review D017723 [Formal programs for assessing drug prescription against some standard. Drug utilization review may consider clinical appropriateness, cost effectiveness, and, in some cases, outcomes. Review is usually retrospective, but some analysis may be done before drugs are dispensed (as in computer systems which advise physicians when prescriptions are entered). Drug utilization review is mandated for Medicaid programs beginning in 1993. ]
Drug and Narcotic Control D004335 [Control of drug and narcotic use by international agreement, or by institutional systems for handling prescribed drugs. This includes regulations concerned with the manufacturing, dispensing, approval (DRUG APPROVAL), and marketing of drugs. ]
Drug-Eluting Stents D054855 [Stents that are covered with materials that are embedded with chemicals that are gradually released into the surrounding milieu. ]
Drug-Related Side Effects and Adverse Reactions D064420 [Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals. ]
Drug-Seeking Behavior D058999 [Activities performed to obtain licit or illicit substances. ]